D2-04: MERIT: a prospective study of putative relationships between tumour biomarkers and clinical benefit from erlotinib in advanced non-small cell lung cancer (NSCLC)

Tan, Eng-Huat; Ramlau, Rodryg; Pluzanska, Anna; Kuo, Han-Pin; Klughammer, Barbara; Kockx, Mark; Carreras, Maximo; Lutz, Verena; Essioux, Laurent; Baselga, Jose

10.1097/01.JTO.0000283260.92476.f6

D2-04: MERIT: a prospective study of putative relationships between tumour biomarkers and clinical benefit from erlotinib in advanced non-small cell lung cancer (NSCLC)

Authors: Eng-Huat Tan
Rodryg Ramlau
Anna Pluzanska
Han-Pin Kuo
Barbara Klughammer
Mark Kockx
Maximo Carreras
Verena Lutz
Laurent Essioux
Jose Baselga
Publication date: 2007
Publisher: International Association for the Study of Lung Cancer. Published by Elsevier Inc.

Abstract

Abstract is not available.

Similar works

Full text

Elsevier - Publisher Connector

Provided original full text link

Last time updated on 6/5/2019

This paper was published in Elsevier - Publisher Connector .

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.